... suspicious for urothelial cancer. The following day the patient was taken to the operation theater to clear the tamponade and perform a TURBT. Intraoperatively, the lesion was described as an exophytic, partly solid bladder cancer with no further tumor detection in the rest of the bladder. Postoperative...

...-free survival (PFS) after urological cancers. Results: A total of 20 studies were eligible. Three studies were on bladder cancer, four on prostate cancer, seven on renal cell carcinoma (RCC), and six on urothelial cancers. Meta-analysis showed that low GNRI was a statistically significant predictor...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Bladder cancer Urothelial cancer MIBC BCG Gender Following the 2018 GLOBOCAN data, urothelial carcinoma of the bladder is the 10th most common malignancy worldwide...

.... 2023 Urothelial cancer Prognostic nutritional index Controlling nutritional status Geriatric nutritional risk index Survival Bladder cancer (BC) continues to be the most common malignancy of the urogenital tract. Estimates suggest that in 2022, 1.6 million individuals were suffering...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Urothelial cancer Bladder cancer Upper urinary tract carcinoma Surgical margin...

... epidermal growth factor receptor 2 ERBB2 gene Urothelial cancer Bladder Trastuzumab Patients with metastatic urothelial carcinoma (UC) show poor response rates to platinum-based chemotherapy as the current standard treatment of care, resulting in a median survival of about 14 months [ 1...

..., instructions or products referred to in the content or advertisements. Local recurrence Muscle-invasive bladder cancer Surgical treatment Urothelial cancer Bladder cancer is the ninth most commonly diagnosed cancer worldwide, with more than 380,000 new cases and 150,000 deaths every year...

...Axel Hegele; Peter Goebell; Ullrich Matz; Thomas Neuhaus Objective: The objective of this retrospective study was to investigate the efficacy and safety of vinflunine monotherapy and the utility of second-line prognostic factors in patients with advanced or metastatic urothelial cancer relapsing...

... aggressiveness and unfavorable prognosis. Gene amplification Double minute chromosomes Urothelial cancer 1 01 1991 19 08 1991 3 2 2010 © 1992 S. Karger AG, Basel 1992 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may...

... and hematuria and 3 individuals exhibited hematuria alone. Cold cup biopsies revealed transitional cell carcinoma in 7 of 9 patients with papillary tumors and in 2 of 3 with nonpapillary tumors. Four patients without ureteroscopic diagnosis of urothelial cancer were found to have invasive tumors on subsequent...

...Mikio Igawa; Hitoshi Kadena; Takatoshi Tacho; Takahisa Nakamoto; Tsuguru Usui Thirty-seven patients with urothelial cancer were given combination chemotherapy with methotrexate, etoposide and cisplatin. Thirty patients were evaluated for response. Response rates were 50% in the primary organ, 50...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Upper urinary tract tumors Urothelial cancer Radical...

... between human urothelial cancer cells and cytokine-activated human endothelial cells. Materials and Methods: We studied the expression of sLe x and sLe a antigens of three bladder cancer cell lines (JTC 30, JTC 32, and T24) by flow cytometry and the adherence to interleukin 1β-activated human umbilical...